High BAALC expression associates with other molecular prognostic markers, poor outcome, and a distinct gene-expression signature in cytogenetically normal patients younger than 60 years with acute myeloid leukemia: a Cancer and Leukemia Group B (CALGB) study

BAALC expression is considered an independent prognostic factor in cytogenetically normal acute myeloid leukemia (CN-AML), but has yet to be investigated together with multiple other established prognostic molecular markers in CN-AML. We analyzed BAALC expression in 172 primary CN-AML patients young...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Langer, Christian, Radmacher, Michael D., Ruppert, Amy S., Whitman, Susan P., Paschka, Peter, Mrózek, Krzysztof, Baldus, Claudia D., Vukosavljevic, Tamara, Liu, Chang-Gong, Ross, Mary E., Powell, Bayard L., de la Chapelle, Albert, Kolitz, Jonathan E., Larson, Richard A., Marcucci, Guido, Bloomfield, Clara D.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2008
Matèries:
Neoplasia
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC2396728/
https://ncbi.nlm.nih.gov/pubmed/18378853
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-11-124958
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars